These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 20399209)

  • 1. Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD.
    Gradilone SA; Masyuk TV; Huang BQ; Banales JM; Lehmann GL; Radtke BN; Stroope A; Masyuk AI; Splinter PL; LaRusso NF
    Gastroenterology; 2010 Jul; 139(1):304-14.e2. PubMed ID: 20399209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD).
    Banales JM; Masyuk TV; Gradilone SA; Masyuk AI; Medina JF; LaRusso NF
    Hepatology; 2009 Jan; 49(1):160-74. PubMed ID: 19065671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.
    Masyuk TV; Masyuk AI; Torres VE; Harris PC; Larusso NF
    Gastroenterology; 2007 Mar; 132(3):1104-16. PubMed ID: 17383431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease.
    Banales JM; Masyuk TV; Bogert PS; Huang BQ; Gradilone SA; Lee SO; Stroope AJ; Masyuk AI; Medina JF; LaRusso NF
    Am J Pathol; 2008 Dec; 173(6):1637-46. PubMed ID: 18988797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease.
    Yoshihara D; Kugita M; Sasaki M; Horie S; Nakanishi K; Abe T; Aukema HM; Yamaguchi T; Nagao S
    PLoS One; 2013; 8(12):e81480. PubMed ID: 24324698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of a cholangiocyte cell line from the PCK rat, an animal model of Autosomal Recessive Polycystic Kidney Disease.
    Muff MA; Masyuk TV; Stroope AJ; Huang BQ; Splinter PL; Lee SO; Larusso NF
    Lab Invest; 2006 Sep; 86(9):940-50. PubMed ID: 16783394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the PI3K/mTOR pathway is involved in cystic proliferation of cholangiocytes of the PCK rat.
    Ren XS; Sato Y; Harada K; Sasaki M; Furubo S; Song JY; Nakanuma Y
    PLoS One; 2014; 9(1):e87660. PubMed ID: 24498161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat.
    Masyuk TV; Huang BQ; Ward CJ; Masyuk AI; Yuan D; Splinter PL; Punyashthiti R; Ritman EL; Torres VE; Harris PC; LaRusso NF
    Gastroenterology; 2003 Nov; 125(5):1303-10. PubMed ID: 14598246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD.
    Park F; Sweeney WE; Jia G; Akbulut T; Mueller B; Falck JR; Birudaraju S; Roman RJ; Avner ED
    Am J Physiol Renal Physiol; 2009 Mar; 296(3):F575-82. PubMed ID: 19129252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Mast Cell Degranulation With Cromolyn Sodium Exhibits Organ-Specific Effects in Polycystic Kidney (PCK) Rats.
    Jiang L; Fang P; Septer S; Apte U; Pritchard MT
    Int J Toxicol; 2018; 37(4):308-326. PubMed ID: 29862868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells.
    Yamaguchi T; Hempson SJ; Reif GA; Hedge AM; Wallace DP
    J Am Soc Nephrol; 2006 Jan; 17(1):178-87. PubMed ID: 16319189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPV4 dysfunction promotes renal cystogenesis in autosomal recessive polycystic kidney disease.
    Zaika O; Mamenko M; Berrout J; Boukelmoune N; O'Neil RG; Pochynyuk O
    J Am Soc Nephrol; 2013 Mar; 24(4):604-16. PubMed ID: 23411787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of Hedgehog Signaling Attenuates Biliary Cystogenesis in the Polycystic Kidney (PCK) Rat.
    Sato Y; Yamamura M; Sasaki M; Harada K
    Am J Pathol; 2018 Oct; 188(10):2251-2263. PubMed ID: 30036521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholangiocyte autophagy contributes to hepatic cystogenesis in polycystic liver disease and represents a potential therapeutic target.
    Masyuk AI; Masyuk TV; Lorenzo Pisarello MJ; Ding JF; Loarca L; Huang BQ; LaRusso NF
    Hepatology; 2018 Mar; 67(3):1088-1108. PubMed ID: 29023824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease.
    Masyuk TV; Radtke BN; Stroope AJ; Banales JM; Masyuk AI; Gradilone SA; Gajdos GB; Chandok N; Bakeberg JL; Ward CJ; Ritman EL; Kiyokawa H; LaRusso NF
    Gastroenterology; 2012 Mar; 142(3):622-633.e4. PubMed ID: 22155366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanosensor transient receptor potential vanilloid member 4 (TRPV4) regulates mouse cholangiocyte secretion and bile formation.
    Li Q; Kresge C; Boggs K; Scott J; Feranchak A
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G277-G287. PubMed ID: 31760763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases.
    Urribarri AD; Munoz-Garrido P; Perugorria MJ; Erice O; Merino-Azpitarte M; Arbelaiz A; Lozano E; Hijona E; Jiménez-Agüero R; Fernandez-Barrena MG; Jimeno JP; Marzioni M; Marin JJ; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Banales JM
    Gut; 2014 Oct; 63(10):1658-67. PubMed ID: 24436140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue culture correlational study of genetic cholangiopathy of autosomal recessive polycystic kidney disease.
    Nakanuma Y; Sato Y; Harada K
    Methods Mol Biol; 2013; 945():303-18. PubMed ID: 23097114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin system activation in congenital hepatic fibrosis in the PCK rat model of autosomal recessive polycystic kidney disease.
    Goto M; Hoxha N; Osman R; Wen J; Wells RG; Dell KM
    J Pediatr Gastroenterol Nutr; 2010 Jun; 50(6):639-44. PubMed ID: 20400910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRPV4 functional status in cystic cells regulates cystogenesis in autosomal recessive polycystic kidney disease during variations in dietary potassium.
    Pyrshev K; Stavniichuk A; Tomilin VN; Khayyat NH; Ren G; Kordysh M; Zaika O; Mamenko M; Pochynyuk O
    Physiol Rep; 2023 Mar; 11(6):e15641. PubMed ID: 36946001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.